Globus Medical (GMED) News Today $92.82 +0.40 (+0.43%) As of 01/24/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Exchange Traded Concepts LLC Sells 26,891 Shares of Globus Medical, Inc. (NYSE:GMED)Exchange Traded Concepts LLC lessened its stake in shares of Globus Medical, Inc. (NYSE:GMED - Free Report) by 14.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 164,425 shares of the medical device cJanuary 24 at 9:58 AM | marketbeat.comEncompass More Asset Management Takes $545,000 Position in Globus Medical, Inc. (NYSE:GMED)Encompass More Asset Management acquired a new stake in Globus Medical, Inc. (NYSE:GMED - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 6,593 shares of the medical device company's stock, valued at approximateJanuary 24 at 9:39 AM | marketbeat.comGlobus Medical FY2025 EPS Estimate Raised by Zacks ResearchJanuary 24 at 4:19 AM | americanbankingnews.comHB Wealth Management LLC Acquires New Shares in Globus Medical, Inc. (NYSE:GMED)HB Wealth Management LLC bought a new position in shares of Globus Medical, Inc. (NYSE:GMED - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 3,634 shares of the medical device company'sJanuary 24 at 3:27 AM | marketbeat.comGlobus Medical Q2 EPS Forecast Boosted by Zacks ResearchJanuary 24 at 2:56 AM | americanbankingnews.comFY2025 EPS Estimates for Globus Medical Raised by AnalystGlobus Medical, Inc. (NYSE:GMED - Free Report) - Research analysts at Zacks Research increased their FY2025 EPS estimates for Globus Medical in a report issued on Tuesday, January 21st. Zacks Research analyst R. Department now anticipates that the medical device company will earn $3.43 per shareJanuary 23 at 9:25 AM | marketbeat.comBrokers Offer Predictions for Globus Medical Q2 EarningsGlobus Medical, Inc. (NYSE:GMED - Free Report) - Equities researchers at Zacks Research lifted their Q2 2025 earnings per share (EPS) estimates for Globus Medical in a note issued to investors on Tuesday, January 21st. Zacks Research analyst R. Department now forecasts that the medical device comJanuary 22 at 6:31 AM | marketbeat.comGlobus Medical (NYSE:GMED) Sets New 52-Week High - Should You Buy?Globus Medical (NYSE:GMED) Hits New 1-Year High - Time to Buy?January 22 at 5:15 AM | marketbeat.comAssenagon Asset Management S.A. Has $7.93 Million Stock Position in Globus Medical, Inc. (NYSE:GMED)Assenagon Asset Management S.A. raised its holdings in Globus Medical, Inc. (NYSE:GMED - Free Report) by 77.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 95,898 shares of the medical device company's stock afterJanuary 20, 2025 | marketbeat.comArtemis Investment Management LLP Grows Position in Globus Medical, Inc. (NYSE:GMED)Artemis Investment Management LLP boosted its stake in Globus Medical, Inc. (NYSE:GMED - Free Report) by 20.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 516,887 shares of the medical device company's stockJanuary 19, 2025 | marketbeat.comOak Thistle LLC Acquires New Shares in Globus Medical, Inc. (NYSE:GMED)Oak Thistle LLC bought a new position in shares of Globus Medical, Inc. (NYSE:GMED - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 4,547 shares of the medical device company's stock, valued at approximately $3January 17, 2025 | marketbeat.comGlobus Medical (NYSE:GMED) Sets New 1-Year High - What's Next?Globus Medical (NYSE:GMED) Reaches New 1-Year High - Time to Buy?January 16, 2025 | marketbeat.comGlobus Medical, Inc. (NYSE:GMED) Shares Sold by Covea FinanceCovea Finance lessened its position in shares of Globus Medical, Inc. (NYSE:GMED - Free Report) by 17.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 250,520 shares of the medical device company's stock after selling 53January 15, 2025 | marketbeat.com279,176 Shares in Globus Medical, Inc. (NYSE:GMED) Acquired by Kathmere Capital Management LLCKathmere Capital Management LLC bought a new position in Globus Medical, Inc. (NYSE:GMED - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 279,176 shares of the medical device company's stock, valued at approJanuary 15, 2025 | marketbeat.comInsider Selling: Globus Medical, Inc. (NYSE:GMED) CFO Sells 14,167 Shares of StockJanuary 15, 2025 | insidertrades.comGlobus Medical, Inc. (NYSE:GMED) CFO Sells $1,250,804.43 in StockGlobus Medical, Inc. (NYSE:GMED - Get Free Report) CFO Keith W. Pfeil sold 14,167 shares of Globus Medical stock in a transaction on Friday, January 10th. The shares were sold at an average price of $88.29, for a total value of $1,250,804.43. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.January 14, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Globus Medical (GMED) and QuidelOrtho (QDEL)January 14, 2025 | markets.businessinsider.comRoth Capital Boosts Earnings Estimates for Globus MedicalGlobus Medical, Inc. (NYSE:GMED - Free Report) - Investment analysts at Roth Capital upped their FY2024 earnings per share (EPS) estimates for shares of Globus Medical in a report issued on Friday, January 10th. Roth Capital analyst J. Wittes now expects that the medical device company will earnJanuary 13, 2025 | marketbeat.comGlobus Medical, Inc. (NYSE:GMED) Given Average Rating of "Moderate Buy" by BrokeragesGlobus Medical, Inc. (NYSE:GMED - Get Free Report) has received an average rating of "Moderate Buy" from the twelve ratings firms that are presently covering the company, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation and nine have given a buy rJanuary 12, 2025 | marketbeat.comGlobus Medical’s Promising Growth and Market Positioning Justify Buy Rating and Increased Price TargetJanuary 10, 2025 | markets.businessinsider.comGlobus Medical price target raised to $101 from $92 at CanaccordJanuary 10, 2025 | markets.businessinsider.comGlobus Medical upgraded to Neutral from Underperform at BofAJanuary 10, 2025 | finance.yahoo.comGlobus Medical (GMED) Gets a Buy from Piper SandlerJanuary 10, 2025 | markets.businessinsider.comCanaccord Genuity Group Forecasts Strong Price Appreciation for Globus Medical (NYSE:GMED) StockCanaccord Genuity Group raised their target price on shares of Globus Medical from $92.00 to $101.00 and gave the company a "buy" rating in a research note on Friday.January 10, 2025 | marketbeat.comGlobus Medical (NYSE:GMED) Reaches New 52-Week High - What's Next?Globus Medical (NYSE:GMED) Sets New 12-Month High - Time to Buy?January 10, 2025 | marketbeat.comB of A Securities Upgrades Globus Medical (GMED)January 10, 2025 | msn.comAnalysts Offer Insights on Healthcare Companies: Globus Medical (GMED) and Reviva Pharmaceuticals Holdings (RVPH)January 10, 2025 | markets.businessinsider.comPositive Outlook and Buy Rating for Globus Medical Amid Strong Sales and Market ConfidenceJanuary 9, 2025 | markets.businessinsider.comNeedham Keeps Their Hold Rating on Globus Medical (GMED)January 9, 2025 | markets.businessinsider.comGlobus Medical upgraded to neutral by BoA on Q4 performanceJanuary 9, 2025 | msn.comGlobus Medical (NYSE:GMED) Rating Increased to Neutral at Bank of AmericaBank of America upgraded shares of Globus Medical from an "underperform" rating to a "neutral" rating and raised their target price for the company from $80.00 to $97.00 in a research note on Thursday.January 9, 2025 | marketbeat.comNeedham & Company LLC Reiterates Hold Rating for Globus Medical (NYSE:GMED)Needham & Company LLC reiterated a "hold" rating on shares of Globus Medical in a research note on Thursday.January 9, 2025 | marketbeat.comGlobus Medical, Inc. (NYSE:GMED) Shares Sold by Diversified Trust CoDiversified Trust Co lowered its holdings in Globus Medical, Inc. (NYSE:GMED - Free Report) by 31.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,811 shares of the medical device company's stockJanuary 9, 2025 | marketbeat.comThe Law Offices of Frank R. Cruz Continues Its Investigation of Globus Medical, Inc. (GMED) on Behalf of InvestorsJanuary 8, 2025 | tmcnet.comGlobus Medical (NYSE:GMED) Updates FY 2025 Earnings GuidanceGlobus Medical (NYSE:GMED) updated its FY 2025 earnings guidance. The company provided EPS guidance of 3.400-3.500 for the period, compared to the consensus estimate of 3.420. The company also issued revenue guidance of $2.7 billionillion-$2.7 billionillion, compared to the consensus estimate of $2.7 billionillion.January 8, 2025 | marketbeat.comGlobus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales ResultsJanuary 8, 2025 | globenewswire.comGlobus Medical (NYSE:GMED) Trading Up 3% - Here's What HappenedGlobus Medical (NYSE:GMED) Trading 3% Higher - Should You Buy?January 8, 2025 | marketbeat.comPrice Over Earnings Overview: Globus MedicalJanuary 7, 2025 | benzinga.comJPMorgan Chase & Co. Sells 31,077 Shares of Globus Medical, Inc. (NYSE:GMED)JPMorgan Chase & Co. decreased its holdings in Globus Medical, Inc. (NYSE:GMED - Free Report) by 1.2% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,604,774 shares of the medical device company's stock after selling 31,077 shares during tJanuary 1, 2025 | marketbeat.comPrincipal Financial Group Inc. Lowers Stock Holdings in Globus Medical, Inc. (NYSE:GMED)Principal Financial Group Inc. reduced its stake in Globus Medical, Inc. (NYSE:GMED - Free Report) by 30.3% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 261,452 shares of the medicalDecember 27, 2024 | marketbeat.comFranklin Resources Inc. Purchases Shares of 53,845 Globus Medical, Inc. (NYSE:GMED)Franklin Resources Inc. acquired a new position in Globus Medical, Inc. (NYSE:GMED - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 53,845 shares of the medical device compDecember 25, 2024 | marketbeat.comQ4 EPS Estimates for Globus Medical Raised by Roth CapitalGlobus Medical, Inc. (NYSE:GMED - Free Report) - Analysts at Roth Capital increased their Q4 2025 EPS estimates for Globus Medical in a research note issued to investors on Monday, December 16th. Roth Capital analyst J. Wittes now anticipates that the medical device company will post earnings ofDecember 19, 2024 | marketbeat.comBarclays PLC Sells 439,883 Shares of Globus Medical, Inc. (NYSE:GMED)Barclays PLC trimmed its position in shares of Globus Medical, Inc. (NYSE:GMED - Free Report) by 82.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 92,601 shares of the medical device company's stock afteDecember 19, 2024 | marketbeat.comPiper Sandler Reaffirms Their Buy Rating on Globus Medical (GMED)December 19, 2024 | markets.businessinsider.comGlobus Medical price target raised to $90 from $85 at TruistDecember 18, 2024 | markets.businessinsider.com16 Analysts Have This To Say About Globus MedicalDecember 18, 2024 | benzinga.comTruist Financial Forecasts Strong Price Appreciation for Globus Medical (NYSE:GMED) StockTruist Financial lifted their price target on shares of Globus Medical from $85.00 to $90.00 and gave the company a "hold" rating in a research report on Wednesday.December 18, 2024 | marketbeat.comRoth Capital Cuts Earnings Estimates for Globus MedicalGlobus Medical, Inc. (NYSE:GMED - Free Report) - Roth Capital dropped their Q1 2025 earnings estimates for Globus Medical in a report released on Monday, December 16th. Roth Capital analyst J. Wittes now expects that the medical device company will earn $0.75 per share for the quarter, down fromDecember 18, 2024 | marketbeat.comGlobus Medical, Inc. (NYSE:GMED) Given Average Rating of "Moderate Buy" by AnalystsShares of Globus Medical, Inc. (NYSE:GMED - Get Free Report) have been assigned an average rating of "Moderate Buy" from the twelve analysts that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recomDecember 18, 2024 | marketbeat.comGlobus Medical (GMED) Gets a Buy from Roth MKMDecember 17, 2024 | markets.businessinsider.com Get Globus Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for GMED and its competitors with MarketBeat's FREE daily newsletter. Email Address GMED Media Mentions By Week GMED Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GMED News Sentiment▼1.170.60▲Average Medical News Sentiment GMED News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GMED Articles This Week▼158▲GMED Articles Average Week Get Globus Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for GMED and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Edwards Lifesciences News ResMed News IDEXX Laboratories News DexCom News STERIS News Insulet News Hologic News Baxter International News Masimo News Teleflex News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:GMED) was last updated on 1/25/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Globus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Globus Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
